Green AJ - Search Results

1

Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease.

Minghetti L, Cardone F, Greco A, Puopolo M, Levi G, Green AJ, Knight R, Pocchiari M. Minghetti L, et al. Among authors: green aj. Neurology. 2002 Jan 8;58(1):127-9. doi: 10.1212/wnl.58.1.127. Neurology. 2002. PMID: 11781418

2

Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified.

Zeidler M, Knight R, Stewart G, Ironside JW, Will RG, Green AJ, Pocchiari M. Zeidler M, et al. Among authors: green aj. BMJ. 1999 Feb 20;318(7182):538. doi: 10.1136/bmj.318.7182.538a. BMJ. 1999. PMID: 10024280 Free PMC article. No abstract available.

3

Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease.

Sharief MK, Green A, Dick JP, Gawler J, Thompson EJ. Sharief MK, et al. Neurology. 1999 Apr 12;52(6):1289-91. doi: 10.1212/wnl.52.6.1289. Neurology. 1999. PMID: 10214763

4

Diagnosis of new variant Creutzfeldt-Jakob disease.

Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K, Green AJ, Knight RS. Will RG, et al. Among authors: green aj. Ann Neurol. 2000 May;47(5):575-82. Ann Neurol. 2000. PMID: 10805327

5

Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.

Green AJ, Knight RS, Macleod MA, Lowman A, Will RG. Green AJ, et al. Neurology. 2001 Apr 10;56(7):986-7. doi: 10.1212/wnl.56.7.986. Neurology. 2001. PMID: 11294951 No abstract available.

6

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.

Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS. Green AJ, et al. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):744-8. doi: 10.1136/jnnp.70.6.744. J Neurol Neurosurg Psychiatry. 2001. PMID: 11385008 Free PMC article.

7

14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.

Green AJ, Ramljak S, Müller WE, Knight RS, Schröder HC. Green AJ, et al. Neurosci Lett. 2002 May 10;324(1):57-60. doi: 10.1016/s0304-3940(02)00172-6. Neurosci Lett. 2002. PMID: 11983294

8

Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease.

Van Everbroeck B, Green AJ, Vanmechelen E, Vanderstichele H, Pals P, Sanchez-Valle R, Corrales NC, Martin JJ, Cras P. Van Everbroeck B, et al. Among authors: green aj. J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):79-81. doi: 10.1136/jnnp.73.1.79. J Neurol Neurosurg Psychiatry. 2002. PMID: 12082054 Free PMC article.

9

Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.

Green AJ. Green AJ. Biochem Soc Trans. 2002 Aug;30(4):382-6. doi: 10.1042/bst0300382. Biochem Soc Trans. 2002. PMID: 12196099 Review.

10

Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.

Choe LH, Green A, Knight RS, Thompson EJ, Lee KH. Choe LH, et al. Electrophoresis. 2002 Jul;23(14):2242-6. doi: 10.1002/1522-2683(200207)23:14<2242::AID-ELPS2242>3.0.CO;2-F. Electrophoresis. 2002. PMID: 12210228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters